Views & Analysis Better customer engagement: Is your data letting you down? The pressure is on for better quality, more granular customer data.
Views & Analysis Behind the buzz of real-world data and real-world evidence Putting the who, where and why of real-world studies into context.
Views & Analysis Web and mobile technologies for health economics modelling Digital apps are more agile than longstanding solutions and allow tailored interrogation of data.
Views & Analysis Tracking studies: moving with the times Awareness, Trial, and Usage tracking can be enhanced if technology updates it in real time.
Views & Analysis Data: underpinning health R&D Big data initiatives positioning the UK as a desirable location for R&D.
Views & Analysis The biggest NHS deficit: not money but data Information gleaned from data is the key to making health services safer, more efficient and cost effective.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
